Ngā hua rapu - Xandra O. Breakefield

Whakamahine hua
  1. 1
    A Defective HSV-1 Vector Expresses <i>Escherichia coli</i> β-Galactosidase in Cultured Peripheral Neurons

    A Defective HSV-1 Vector Expresses <i>Escherichia coli</i> β-Galactosidase in Cultured Peripheral Neurons mā Alfred I. Geller, Xandra O. Breakefield

    I whakaputaina 1988
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Altered nerve growth factor in fibroblasts from patients with familial dysautonomia.

    Altered nerve growth factor in fibroblasts from patients with familial dysautonomia. mā Joan P. Schwartz, Xandra O. Breakefield

    I whakaputaina 1980
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake

    Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake mā Erik R. Abels, Xandra O. Breakefield

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Role of Exosomes/Microvesicles in the Nervous System and Use in Emerging Therapies

    Role of Exosomes/Microvesicles in the Nervous System and Use in Emerging Therapies mā Charles Pin‐Kuang Lai, Xandra O. Breakefield

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Gesicles: Microvesicle “Cookies” for Transient Information Transfer Between Cells

    Gesicles: Microvesicle “Cookies” for Transient Information Transfer Between Cells mā Xandra O. Breakefield, Robert Frederickson, Richard J. Simpson

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.

    Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. mā Pat Levitt, John E. Pintar, Xandra O. Breakefield

    I whakaputaina 1982
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    TorsinA

    TorsinA mā Xandra O. Breakefield, Christoph Kamm, Phyllis I. Hanson

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Extracellular vesicles: emerging targets for cancer therapy

    Extracellular vesicles: emerging targets for cancer therapy mā Pieter Vader, Xandra O. Breakefield, Matthew J. A. Wood

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis

    In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis mā Khalid Shah, Ching‐Hsuan Tung, Xandra O. Breakefield, Ralph Weissleder

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Voltage-sensitive calcium channels regulate guanosine 3',5'-cyclic monophosphate levels in neuroblastoma cells.

    Voltage-sensitive calcium channels regulate guanosine 3',5'-cyclic monophosphate levels in neuroblastoma cells. mā Robert E. Study, Xandra O. Breakefield, Tamás Bartfai, Paul Greengard

    I whakaputaina 1978
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Presence of free cyclic AMP receptor protein and regulation of its level by cyclic AMP in neuroblastoma-glioma hybrid cells.

    Presence of free cyclic AMP receptor protein and regulation of its level by cyclic AMP in neuroblastoma-glioma hybrid cells. mā Ulrich Walter, M R Costa, Xandra O. Breakefield, Paul Greengard

    I whakaputaina 1979
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Therapeutic Applications of Extracellular Vesicles: Clinical Promise and Open Questions

    Therapeutic Applications of Extracellular Vesicles: Clinical Promise and Open Questions mā Bence György, Michelle Hung, Xandra O. Breakefield, Joshua N. Leonard

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Noninvasive In Vivo Monitoring of Extracellular Vesicles

    Noninvasive In Vivo Monitoring of Extracellular Vesicles mā Charles Pin‐Kuang Lai, Bakhos A. Tannous, Xandra O. Breakefield

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    HSV-1 Amplicon Vectors—Simplicity and Versatility

    HSV-1 Amplicon Vectors—Simplicity and Versatility mā Miguel Sena‐Esteves, Yoshinaga Saeki, Cornel Fraefel, Xandra O. Breakefield

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Extracellular Vesicles: Unique Intercellular Delivery Vehicles

    Extracellular Vesicles: Unique Intercellular Delivery Vehicles mā Sybren L. N. Maas, Xandra O. Breakefield, Alissa M. Weaver

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Gene therapy in the CNS

    Gene therapy in the CNS mā Lauren C. Costantini, Joanna C. Bakowska, Xandra O. Breakefield, Ole Isacson

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress

    A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress mā Christian E. Badr, Jeffrey Hewett, Xandra O. Breakefield, Bakhos A. Tannous

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Engineered EVs designed to target diseases of the CNS

    Engineered EVs designed to target diseases of the CNS mā Lisa Nieland, Shadi Mahjoum, Emily Grandell, Koen Breyne, Xandra O. Breakefield

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Improved Helper Virus-Free Packaging System for HSV Amplicon Vectors Using an ICP27-Deleted, Oversized HSV-1 DNA in a Bacterial Artificial Chromosome

    Improved Helper Virus-Free Packaging System for HSV Amplicon Vectors Using an ICP27-Deleted, Oversized HSV-1 DNA in a Bacterial Artificial Chromosome mā Yoshinaga Saeki, Cornel Fraefel, Tomotsugu Ichikawa, Xandra O. Breakefield, E. Antonio Chiocca

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Extracellular RNA mediates and marks cancer progression

    Extracellular RNA mediates and marks cancer progression mā Jasmina S. Redzic, Leonora Balaj, Kristan E. van der Vos, Xandra O. Breakefield

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: